Kelsian Group (ASX:KLS) announced plans to explore the divestment of its Australian tourism assets to streamline operations, reduce debt, and enhance shareholder value. The Tourism Portfolio under ...

Artrya (ASX:AYA) has signed a commercial contract with Lumus Imaging, a diagnostic imaging provider in Australia. The partnership will see Lumus Imaging integrate Artrya's Salix Coronary Anatomy ...

AVJennings (ASX:AVJ) has signed a scheme implementation deed with PM Nominees C, an investment entity of Proprium Capital Partners and AVID Property Group, to acquire all AVJennings shares for $0.655 ...

Warner Bros Discovery's (NASDAQ:WBD) streaming service, Max, has officially launched in Australia, with its global chief, Jean-Briac Perrette, predicting profitability within two to three years. The ...

Corcept Therapeutics Incorporated (NASDAQ:CORT), a leader in developing medications for severe endocrinologic, oncologic, metabolic, and neurologic disorders through cortisol modulation, has announced ...

Shares of U.S. biotech companies experienced a sharp decline in premarket trading on Monday, with some falling as much as 10%, following reports of the resignation of a key Food and Drug ...

Shares of electric vehicle giant Tesla (NASDAQ:TSLA) fell 5.3% to $249.6 in premarket trading on Monday, following a downgrade from Stifel. The brokerage cut its price target on Tesla stock from $474 ...

The U.S. Food and Drug Administration (FDA) has approved AstraZeneca’s (NASDAQ:AZN) Imfinzi (durvalumab) in combination with gemcitabine and cisplatin as a neoadjuvant treatment, followed by Imfinzi ...

Ethereum’s (CRYPTO:ETH) position as the largest altcoin by market cap faces scrutiny amid Bitcoin’s (CRYPTO:BTC) political and ideological resurgence, though its Layer-2 growth and upcoming Pectra ...

FTX’s (CRYPTO:FTT) bankruptcy estate plans to begin cash repayments of $11.4 billion to primary creditors by May 30, 2025, using funds accumulated since its collapse in 2022. The disbursements follow ...

Orora (ASX:ORA) has provided an update on the ongoing investigation by the French Competition Authority into the manufacture and marketing of glass packaging in France. The company confirmed that the ...

LAVA Therapeutics (NASDAQ:LVTX), a clinical-stage immuno-oncology company advancing its proprietary Gammabody® platform of bispecific gamma delta T cell engagers, today released its financial results ...